IGM-55.5, a novel monoclonal human recombinant IgM antibody with potent activity against B cell leukemia and lymphoma

AACR Annual Meeting – April 5-9, 2014

Omar Duramad, Beatrice Wang, Fen Zhang, Lena Keyt, Claire Repellin, Lucia Beviglia, Neelima Bhat, Marcia Bieber, Nelson Teng and Bruce Keyt

IGM Biosciences, Inc. – Research and Development, SRI International – Cancer Pharmacology, Stanford – Department of Obstetrics and Gynecology

View the full poster here. (940Kb PDF)

Posted in publications.